Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women - time for policies to change Comment

Hilde Engjom; Thomas van den Akker; Anna Aabakke; Outi Ayras; Kitty Bloemenkamp; Serena Donati; Danilo Cereda; Evelien Overtoom; Marian Knight

doi:10.1016/j.lanepe.2022.100313

Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women - time for policies to change Comment

Hilde Engjom, Thomas van den Akker, Anna Aabakke, Outi Ayras, Kitty Bloemenkamp, Serena Donati, Danilo Cereda, Evelien Overtoom, Marian Knight

Gynækologisk og Obstetrisk Afd.

54 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	100313
Tidsskrift	The Lancet regional health. Europe
Vol/bind	13
Sider (fra-til)	100313
DOI	https://doi.org/10.1016/j.lanepe.2022.100313
Status	Udgivet - feb. 2022

Adgang til dokumentet

10.1016/j.lanepe.2022.100313

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{14d83f765d314475a3fee257dfefb6a0,

title = "Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women - time for policies to change Comment",

author = "Hilde Engjom and {van den Akker}, Thomas and Anna Aabakke and Outi Ayras and Kitty Bloemenkamp and Serena Donati and Danilo Cereda and Evelien Overtoom and Marian Knight",

year = "2022",

month = feb,

doi = "10.1016/j.lanepe.2022.100313",

language = "English",

volume = "13",

pages = "100313",

journal = "The Lancet regional health. Europe",

issn = "2666-7762",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women - time for policies to change Comment

AU - Engjom, Hilde

AU - van den Akker, Thomas

AU - Aabakke, Anna

AU - Ayras, Outi

AU - Bloemenkamp, Kitty

AU - Donati, Serena

AU - Cereda, Danilo

AU - Overtoom, Evelien

AU - Knight, Marian

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85123713231&partnerID=8YFLogxK

U2 - 10.1016/j.lanepe.2022.100313

DO - 10.1016/j.lanepe.2022.100313

M3 - Comment/debate

C2 - 35098198

SN - 2666-7762

VL - 13

SP - 100313

JO - The Lancet regional health. Europe

JF - The Lancet regional health. Europe

M1 - 100313

ER -